The Ventricular Assist Device market is expected to be around US$ 2.8 Billion by 2028 at a CAGR of 8.9% in the given forecast period.
Ventricular assist devices are mechanical pumps that help patients with weaker hearts maintain cardiac circulation. The global ventricular assist devices market is being driven by two key factors: an increase in the number of people with heart failure and a scarcity of heart donors. In addition, the introduction of technologically improved VAD (DuraHeart, HeartMate III) is propelling the market forward. However, significant limitations of these devices, including as their expensive cost and the substantial dangers associated with VAD implantation, such as blood clots and bleeding, limit market expansion.
Previously, the devices utilised had several flaws, including a significant risk of infection, thrombus formation, and blood trauma. As a result, VADs have been modified to improve efficiency and durability to overcome such issues. The second-generation device HeartMate II, for example, showed improved functional capacity and performance.
The global Ventricular Assist Device market is segregated on the basis of Product as Left Ventricular Assist Device, Right Ventricular Assist Device, Biventricular Assist Device, and Total Artificial Heart. Based on Design the global Ventricular Assist Device market is segmented in Implantable Ventricular Assist Device and Transcutaneous Ventricular Assist Device. Based on Type of Flow the global Ventricular Assist Device market is segmented in Pulsatile Flow and Continuous Flow.
Based on Application, the global Ventricular Assist Device market is segmented in Destination therapy, Bridge-to-candidacy (BTC) therapy, Bridge-to-transplant (BTT) therapy, Bridge-to-recovery (BTR) therapy, and Others.
The global Ventricular Assist Device market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Ventricular Assist Device market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Abiomed Inc., BiVACOR Inc., Abbott Laboratories (St. Jude Medical Inc.), Berlin Heart GmbH, Calon Cardio, Jarvik Heart Inc., MAQUET Holding BV & Co. KG, Medtronic PLC, SynCardia Systems LLC, Terumo Corporation, and others are among the major players in the global Ventricular Assist Device market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Ventricular Assist Device Market has been segmented as below:
Ventricular Assist Device Market, By Product
Ventricular Assist Device Market, By Design
Ventricular Assist Device Market, By Type of Flow
Ventricular Assist Device Market, By Application
Ventricular Assist Device Market, By Region
Ventricular Assist Device Market, By Company
The report covers:
Report Scope:
The global Ventricular Assist Device market report scope includes detailed study covering underlying factors influencing the industry trends. The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Ventricular Assist Device market share. Major industry players with significant revenue share include Abiomed Inc., BiVACOR Inc., Abbott Laboratories (St. Jude Medical Inc.), Berlin Heart GmbH, Calon Cardio, Jarvik Heart Inc., MAQUET Holding BV & Co. KG, Medtronic PLC, SynCardia Systems LLC, Terumo Corporation, and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations
Below are our new reports:
Automated External Defibrillator Market
Intracranial Pressure Monitors Market
Minimally Invasive Medical Robotics Market
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter’s Five Force Analysis
5. Ventricular Assist Device Market, By Product
5.1 Introduction
5.2 Left Ventricular Assist Device
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Right Ventricular Assist Device
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Biventricular Assist Device
5.4.1 Market Overview
5.4.2 Market Size and Forecast
5.5 Total Artificial Heart
5.5.1 Market Overview
5.5.2 Market Size and Forecast
6. Ventricular Assist Device Market, By Design
6.1 Introduction
6.2 Implantable Ventricular Assist Device
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Transcutaneous Ventricular Assist Device
6.3.1 Market Overview
6.3.2 Market Size and Forecast
7. Ventricular Assist Device Market, By Type Of Flow
7.1 Introduction
7.2 Pulsatile Flow
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 Continuous Flow
7.3.1 Market Overview
7.3.2 Market Size and Forecast
8. Ventricular Assist Device Market, By Application
8.1 Introduction
8.2 Destination therapy
8.2.1 Market Overview
8.2.2 Market Size and Forecast
8.3 Bridge-to-candidacy (BTC) therapy
8.3.1 Market Overview
8.3.2 Market Size and Forecast
8.4 Bridge-to-transplant (BTT) therapy
8.4.1 Market Overview
8.4.2 Market Size and Forecast
8.5 Bridge-to-recovery (BTR) therapy
8.5.1 Market Overview
8.5.2 Market Size and Forecast
8.6 Others
8.6.1 Market Overview
8.6.2 Market Size and Forecast
9. Ventricular Assist Device Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 North America Ventricular Assist Device, By Product
9.2.2 North America Ventricular Assist Device, By Design
9.2.3 North America Ventricular Assist Device, By Type of Flow
9.2.4 North America Ventricular Assist Device, By Application
9.3 Europe
9.3.1 Europe Ventricular Assist Device, By Product
9.3.2 Europe Ventricular Assist Device, By Design
9.3.3 Europe Ventricular Assist Device, By Type of Flow
9.3.4 Europe Ventricular Assist Device, By Application
9.4 Asia-Pacific
9.4.1 Asia-Pacific Ventricular Assist Device, By Product
9.4.2 Asia-Pacific Ventricular Assist Device, By Design
9.4.3 Asia-Pacific Ventricular Assist Device, By Type of Flow
9.4.4 Asia-Pacific Ventricular Assist Device, By Application
9.5 Rest of the World
9.5.1 Rest of the World Ventricular Assist Device, By Product
9.5.2 Rest of the World Ventricular Assist Device, By Design
9.5.3 Rest of the World Ventricular Assist Device, By Type of Flow
9.5.4 Rest of the World Ventricular Assist Device, By Application
10. Competitive Insights
10.1 Key Insights
10.2 Company Market Share Analysis
10.3 Strategic Outlook
10.3.1 Mergers & Acquisitions
10.3.2 New Product Development
10.3.3 Portfolio/Production Capacity Expansions
10.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
10.3.5 Others
11. Company Profiles
11.1 Abiomed Inc.
11.1.1 Company Overview
11.1.2 Product/Service Landscape
11.1.3 Financial Overview
11.1.4 Recent Developments
11.2 BiVACOR Inc.
11.2.1 Company Overview
11.2.2 Product/Service Landscape
11.2.3 Financial Overview
11.2.4 Recent Developments
11.3 Abbott Laboratories (St. Jude Medical Inc.)
11.3.1 Company Overview
11.3.2 Product/Service Landscape
11.3.3 Financial Overview
11.3.4 Recent Developments
11.4 Berlin Heart GmbH
11.4.1 Company Overview
11.4.2 Product/Service Landscape
11.4.3 Financial Overview
11.4.4 Recent Developments
11.5 Calon Cardio
11.5.1 Company Overview
11.5.2 Product/Service Landscape
11.5.3 Financial Overview
11.5.4 Recent Developments
11.6 Jarvik Heart Inc.
11.6.1 Company Overview
11.6.2 Product/Service Landscape
11.6.3 Financial Overview
11.6.4 Recent Developments
11.7 MAQUET Holding BV & Co. KG
11.7.1 Company Overview
11.7.2 Product/Service Landscape
11.7.3 Financial Overview
11.7.4 Recent Developments
11.8 Medtronic PLC
11.8.1 Company Overview
11.8.2 Product/Service Landscape
11.8.3 Financial Overview
11.8.4 Recent Developments
11.9 SynCardia Systems LLC
11.9.1 Company Overview
11.9.2 Product/Service Landscape
11.9.3 Financial Overview
11.9.4 Recent Developments
11.10 Terumo Corporation
11.10.1 Company Overview
11.10.2 Product/Service Landscape
11.10.3 Financial Overview
11.10.4 Recent Developments
The Ventricular Assist Device Market has been segmented as below:
Ventricular Assist Device Market, By Product
Ventricular Assist Device Market, By Design
Ventricular Assist Device Market, By Type of Flow
Ventricular Assist Device Market, By Application
Ventricular Assist Device Market, By Region
Ventricular Assist Device Market, By Company
